alpha-Phellandrene is a monoterpene hydrocarbon found in several aromatic oils in the AromaForge archive, especially angelica root, dill, eucalyptus dives style oils, pink pepper, and elemi. Public literature supports its identity and repeated occurrence well, while its biological evidence is still mostly preclinical, with animal and cell studies around inflammatory signaling, nociception, and immune activity. For archive use, it is best described as a composition marker with early-stage mechanistic research rather than a basis for medical claims.
Chemical identity and composition
PubChem lists alpha-phellandrene as CID 7460 with formula C10H16 and IUPAC name 2-methyl-5-propan-2-ylcyclohexa-1,3-diene. In the local archive it appears at substantial levels in pink pepper essential oil (22.98%), dill weed Oregon (17.80%), elemi (14%), angelica root Serbia (8.5%), and peppermint eucalyptus / eucalyptus dives style material (25.55%), making it a meaningful profile constituent rather than a trace-only marker.
Aroma and practical use
- Use the recorded peppery, terpenic, citrus-like, green, citrus descriptors to explore a blend's scent character; perceived strength also depends on the other ingredients.
- Compare the recorded goal signals with the intended purpose, while keeping model assumptions separate from observed study outcomes.
- Review the flagged use concerns across every contributing oil and the selected dilution.
- Read the route, preparation and experimental context before using a study finding to choose an oil.
Reported benefits and effects
Findings retain their study context. An animal or laboratory result describes that experiment.
A rodent pharmacology study reported antinociceptive activity for alpha-phellandrene across experimental nociception models and discussed possible central and peripheral mechanisms.
A rodent pharmacology study reported antinociceptive activity for alpha-phellandrene across experimental nociception models and discussed possible central and peripheral mechanisms.
This experimental finding does not establish benefit, dose or safety in people using this blend.
An in vivo mouse study reported that alpha-phellandrene enhanced macrophage phagocytosis and natural killer cell activities in normal BALB/c mice.
An in vivo mouse study reported that alpha-phellandrene enhanced macrophage phagocytosis and natural killer cell activities in normal BALB/c mice.
This experimental finding does not establish benefit, dose or safety in people using this blend.
A 2016 study reported that alpha-phellandrene attenuated inflammatory response through neutrophil migration inhibition and mast-cell degranulation modulation.
A 2016 study reported that alpha-phellandrene attenuated inflammatory response through neutrophil migration inhibition and mast-cell degranulation modulation.
This experimental finding does not establish benefit, dose or safety in people using this blend.
A later wound-healing paper evaluated alpha-phellandrene alongside terpinolene in vitro and described antioxidant and anti-inflammatory related activity in that exploratory setting.
A later wound-healing paper evaluated alpha-phellandrene alongside terpinolene in vitro and described antioxidant and anti-inflammatory related activity in that exploratory setting.
This experimental finding does not establish benefit, dose or safety in people using this blend.
How it contributes to goal calculations
Model markers guide the formulation score. They are separate from the source findings above.
Use concerns and concentration limits
Sensitization concernFlagged
Flagged in the constituent reference; assess the source, route and finished-product concentration.
Phototoxicity concernNot flagged
Not flagged in the current model. This is not proof of absence or unrestricted safety.
Oxidation concernFlagged
Flagged in the constituent reference; assess the source, route and finished-product concentration.
Penetration enhancementNot flagged
Not flagged in the current model. This is not proof of absence or unrestricted safety.
No numeric constituent-specific use limit is available here. Missing is not an unrestricted-use clearance.
A workplace analytical reference notes that alpha-phellandrene can form peroxides and that oxidation products in contact with air or skin may act as pro-haptens associated with allergy risk.
The source assessment applies to its specified exposure and preparation; this entry is not an unrestricted-use clearance.
No direct public citation is attached to this entry.
A supplier safety listing classifies alpha-phellandrene as flammable and aspiration-hazard relevant, so constituent descriptions should not imply casual internal use safety.
The source assessment applies to its specified exposure and preparation; this entry is not an unrestricted-use clearance.
No direct public citation is attached to this entry.
No constituent-specific IFRA dermal limit or human clinical safety program was verified in this pass.
This reference does not establish a therapeutic result or a safe use level for a custom oil blend.
No direct public citation is attached to this entry.
Constituents it may interact with
No constituent-pair interaction is recorded for this identity. The report does not assume either amplification or incompatibility.
How the effects were investigated
neutrophil migration modulation
The clearest mechanism signal in the located literature is attenuation of inflammatory response through neutrophil migration inhibition.
This experimental finding does not establish benefit, dose or safety in people using this blend.
No direct public citation is attached to this entry.
mast cell stabilization related signal
A PubMed-indexed inflammatory study also linked alpha-phellandrene to reduced mast-cell degranulation in preclinical models.
This experimental finding does not establish benefit, dose or safety in people using this blend.
No direct public citation is attached to this entry.
What this report cannot establish
- A reported constituent percentage does not establish an effective human therapeutic dose or the amount absorbed into the body.
- The presence of a constituent does not guarantee a clinical benefit, rash treatment or sleep improvement from a custom blend.
- An unflagged concern or missing use limit does not establish safety for ingestion, inhalation, skin exposure or a particular person.
- A candidate constituent interaction does not establish that two oils amplify one another at the selected proportions.
- Constituent descriptors alone do not establish a precise top, heart or base lifetime in a finished blend.
Known data gaps (5)
- No human clinical efficacy studies specific to isolated alpha-phellandrene were verified in this pass.
- Most positive findings are animal or in vitro results rather than practical aroma-use evidence.
- Constituent-specific dermal sensitization thresholds and finished-product use limits remain unclear in public sources.
- No constituent-specific numeric dermal reference is available here.
- Some findings do not record an explicit exposure route; consult the linked study before applying them to a use.